Loncar China BioPharma ETF is a ETF series of ETF Series Solutions (series S000062680). Net assets $4.2M as of 2023-08-31. Index fund.
Showing 15 of 67 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| AIM Vaccine Co Ltd | — | $185K | 445.40% |
| Legend Biotech Corp | — | $128K | 307.08% |
| WuXi AppTec Co Ltd | — | $112K | 270.20% |
| Sinopharm Group Co Ltd | — | $106K | 256.05% |
| BeiGene Ltd | — | $105K | 253.06% |
| HAOHAI BIOTEC | — | $103K | 246.70% |
| FOSUN PHARMA | — | $95K | 229.28% |
| BAIYUNSHAN PH | — | $87K | 209.63% |
| SH PHARMA | — | $85K | 204.53% |
| Wuxi Biologics Cayman Inc | — | $84K | 203.10% |
| CSPC Pharmaceutical Group Ltd | — | $83K | 200.62% |
| Hansoh Pharmaceutical Group Co | — | $83K | 200.20% |
| Sino Biopharmaceutical Ltd | — | $83K | 199.68% |
| LIVZON GROUP | — | $82K | 197.15% |
| CKLIFE SCIENCES | — | $82K | 196.11% |
| Report date | Net assets |
|---|---|
| 2023-08-31 | $4.2M |
| 2023-05-31 | $4.5M |
| 2023-02-28 | $5.8M |
| 2022-11-30 | $5.4M |
| 2022-08-31 | $5.3M |
| 2022-05-31 | $5.4M |
| 2022-02-28 | $6.7M |
| 2021-11-30 | $11.7M |